Skip to content

Released Nov 3, 2022, before the open

10-Q filed Nov 3, 2022, 34 days after period end · 0000950170-22-021538

Q3 2022 · 10-Q
Revenue$114.00M+1.4% vs Q3 2021−3.5% vs Q2 2022
Net Income-$10.72MN/M vs Q3 2021N/M vs Q2 2022
EPS Diluted-$0.53N/M vs Q3 2021N/M vs Q2 2022
Gross Profit$83,423,000−0.8%
Operating Income-$5,787,000N/M
Operating Cash Flowderived-$1,264,000N/M
Free Cash Flowderived-$6,391,000N/M
Margins · derived
Gross margin73.2%−1.6 pt vs Q3 2021
Operating margin-5.1%−4.8 pt vs Q3 2021
Net margin-9.4%−7.5 pt vs Q3 2021

What the release said

The release

Same quarter

MetricQ3 2022Q3 2021Q3 2020Q3 2019
Revenue$114.00M$112.43M$110.99M$113.50M
Net Income-$10.72M-$2.17M$4.65M-$40.50M
EPS Diluted-$0.53$0.11$0.24-$2.14

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR